Gina Lambiase joined Ensem Therapeutics in February 2024 as our Head of Finance. Previously, Gina served as Head of Finance for Greenlight Biosciences and prior to that spent a number of years at Epizyme Therapeutics. She was the Executive Director of Finance for Epizyme and lead financial strategy and operations during the transition of being a research focused company into a commercial entity. She was mainly focused on spearheading FP&A initiatives to drive the transition along with optimizing forecasting, budgeting, and financial analysis processes. Gina has more than 20 years of Finance experience across several industries – Biotech, Banking, Retail and Entertainment.

Gina holds an B.A. in Finance from Bryant University.